773 related articles for article (PubMed ID: 16971347)
1. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
2. Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats.
Varanasi KK; Potharaju S; Rajak S; Veeraraghavan S; Mallick P; Vakkalanka SK
Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):537-42. PubMed ID: 18985182
[TBL] [Abstract][Full Text] [Related]
3. Influence of cholestyramine on the pharmacokinetics of cerivastatin.
Mück W; Ritter W; Frey R; Wetzelsberger N; Lücker PW; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):250-4. PubMed ID: 9208341
[TBL] [Abstract][Full Text] [Related]
4. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
5. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of pioglitazone in Thai healthy subjects.
Wittayalertpanya S; Chompootaweep S; Thaworn N
J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
[TBL] [Abstract][Full Text] [Related]
7. Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans.
Kim KA; Park PW; Kim KR; Park JY
Br J Clin Pharmacol; 2007 Mar; 63(3):339-45. PubMed ID: 16981900
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
[TBL] [Abstract][Full Text] [Related]
10. Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats.
Jajoo HK; Mamidi RN; Vakkalanka SV; Sathyavageeswaran S; Katneni K; Ayalasomayajula PS; Rao BP; Lohray BB; Subramaniam S
Arzneimittelforschung; 1999 Feb; 49(2):133-6. PubMed ID: 10083982
[TBL] [Abstract][Full Text] [Related]
11. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
Song KH; Fasano A; Eddington ND
Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
[TBL] [Abstract][Full Text] [Related]
12. Effect of quercetin on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in healthy subjects.
Kim KA; Park PW; Kim HK; Ha JM; Park JY
J Clin Pharmacol; 2005 Aug; 45(8):941-6. PubMed ID: 16027405
[TBL] [Abstract][Full Text] [Related]
13. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
[TBL] [Abstract][Full Text] [Related]
14. Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats.
Choi JS; Koh YY; Chung JH; Choi DH; Han HK
J Pharm Pharmacol; 2008 Oct; 60(10):1403-7. PubMed ID: 18812034
[TBL] [Abstract][Full Text] [Related]
15. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
Liu XL; Tang J; Song J; He J; Xu P; Peng WX
Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
Zhong DF; Li K; Xu JH; Du Y; Zhang YF
Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
[TBL] [Abstract][Full Text] [Related]
17. Effect of probucol on the oral bioavailability of cyclosporine A.
Sugimoto K; Sudoh T; Tsuruoka S; Yamamoto Y; Maezono S; Watanabe Y; Fujimura A
Eur J Pharm Sci; 2004 May; 22(1):71-7. PubMed ID: 15113585
[TBL] [Abstract][Full Text] [Related]
18. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
Low BS; Ng BH; Choy WP; Yuen KH; Chan KL
Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]